Literature DB >> 34551425

Efficient and targeted COVID-19 border testing via reinforcement learning.

Hamsa Bastani1, Kimon Drakopoulos2, Vishal Gupta3, Ioannis Vlachogiannis4, Christos Hadjichristodoulou5, Pagona Lagiou6, Gkikas Magiorkinis6, Dimitrios Paraskevis6, Sotirios Tsiodras7.   

Abstract

Throughout the coronavirus disease 2019 (COVID-19) pandemic, countries have relied on a variety of ad hoc border control protocols to allow for non-essential travel while safeguarding public health, from quarantining all travellers to restricting entry from select nations on the basis of population-level epidemiological metrics such as cases, deaths or testing positivity rates1,2. Here we report the design and performance of a reinforcement learning system, nicknamed Eva. In the summer of 2020, Eva was deployed across all Greek borders to limit the influx of asymptomatic travellers infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to inform border policies through real-time estimates of COVID-19 prevalence. In contrast to country-wide protocols, Eva allocated Greece's limited testing resources on the basis of incoming travellers' demographic information and testing results from previous travellers. By comparing Eva's performance against modelled counterfactual scenarios, we show that Eva identified 1.85 times as many asymptomatic, infected travellers as random surveillance testing, with up to 2-4 times as many during peak travel, and 1.25-1.45 times as many asymptomatic, infected travellers as testing policies that utilize only epidemiological metrics. We demonstrate that this latter benefit arises, at least partially, because population-level epidemiological metrics had limited predictive value for the actual prevalence of SARS-CoV-2 among asymptomatic travellers and exhibited strong country-specific idiosyncrasies in the summer of 2020. Our results raise serious concerns on the effectiveness of country-agnostic internationally proposed border control policies3 that are based on population-level epidemiological metrics. Instead, our work represents a successful example of the potential of reinforcement learning and real-time data for safeguarding public health.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34551425     DOI: 10.1038/s41586-021-04014-z

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  5 in total

1.  Surveillance for endemic infectious disease outbreaks: Adaptive sampling using profile likelihood estimation.

Authors:  Michael Fairley; Isabelle J Rao; Margaret L Brandeau; Gary L Qian; Gregg S Gonsalves
Journal:  Stat Med       Date:  2022-05-08       Impact factor: 2.497

2.  Context-specific emergence and growth of the SARS-CoV-2 Delta variant.

Authors:  John T McCrone; Verity Hill; Sumali Bajaj; Rosario Evans Pena; Ben C Lambert; Rhys Inward; Samir Bhatt; Erik Volz; Christopher Ruis; Simon Dellicour; Guy Baele; Alexander E Zarebski; Adam Sadilek; Neo Wu; Aaron Schneider; Xiang Ji; Jayna Raghwani; Ben Jackson; Rachel Colquhoun; Áine O'Toole; Thomas P Peacock; Kate Twohig; Simon Thelwall; Gavin Dabrera; Richard Myers; Nuno R Faria; Carmen Huber; Isaac I Bogoch; Kamran Khan; Louis du Plessis; Jeffrey C Barrett; David M Aanensen; Wendy S Barclay; Meera Chand; Thomas Connor; Nicholas J Loman; Marc A Suchard; Oliver G Pybus; Andrew Rambaut; Moritz U G Kraemer
Journal:  Res Sq       Date:  2021-12-20

3.  Context-specific emergence and growth of the SARS-CoV-2 Delta variant.

Authors:  John T McCrone; Verity Hill; Sumali Bajaj; Rosario Evans Pena; Ben C Lambert; Rhys Inward; Samir Bhatt; Erik Volz; Christopher Ruis; Simon Dellicour; Guy Baele; Alexander E Zarebski; Adam Sadilek; Neo Wu; Aaron Schneider; Xiang Ji; Jayna Raghwani; Ben Jackson; Rachel Colquhoun; Áine O'Toole; Thomas P Peacock; Kate Twohig; Simon Thelwall; Gavin Dabrera; Richard Myers; Nuno R Faria; Carmen Huber; Isaac I Bogoch; Kamran Khan; Louis du Plessis; Jeffrey C Barrett; David M Aanensen; Wendy S Barclay; Meera Chand; Thomas Connor; Nicholas J Loman; Marc A Suchard; Oliver G Pybus; Andrew Rambaut; Moritz U G Kraemer
Journal:  medRxiv       Date:  2021-12-21

4.  Emerging and Re-Emerging Infectious Diseases: Humankind's Companions and Competitors.

Authors:  Nikolaos Spernovasilis; Sotirios Tsiodras; Garyphallia Poulakou
Journal:  Microorganisms       Date:  2022-01-04

5.  Identifying Country-Level Risk Factors for the Spread of COVID-19 in Europe Using Machine Learning.

Authors:  Serafeim Moustakidis; Christos Kokkotis; Dimitrios Tsaopoulos; Petros Sfikakis; Sotirios Tsiodras; Vana Sypsa; Theoklis E Zaoutis; Dimitrios Paraskevis
Journal:  Viruses       Date:  2022-03-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.